![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
20
Shaoxing Jingxin Pharmaceutical Co., Ltd. Shangyu Cn, based in China, is a pharmaceutical company that stands out with its certifications from EDQM.
One of their significant offerings is Levetiracetam, Process II, supported by a 'Valid' Certificate of Suitability (CEP) with the number CEP 2021-267 - Rev 01
This Chemical Type CEP, issued on January 29, 2024, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 2535 associated with this CEP further emphasizes